Hyperglycemia induces the variations of 11β-hydroxysteroid dehydrogenase type 1 and peroxisome proliferator-activated receptor-γ expression in hippocampus and hypothalamus of diabetic rats

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Qi, Wen Wen ^a   Zhong, Li Yong ^a   Li, Xiao Rong ^a   Li, Guang ^a   Liu, Zhao Xia ^a   Hu, Jin Feng ^b   Chen, Nai Hong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; CORTICOTROPIN; DEHYDROCORTICOSTERONE; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CORTICOSTEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; SPRAGUE DAWLEY RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADRENAL CORTEX HORMONES; ANIMALS; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOTHALAMUS; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84864934665     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/107130     Document Type: Article

References (21)

1. Kamboj S. S., Chopra K., Sandhir R., Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes Metabolic Brain Disease 2008 23 4 427 443
2. Manschot S. M., Biessels G. J., Cameron N. E., Cotter M. A., Kamal A., Kappelle L. J., Gispen W. H., Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats Brain Research 2003 966 2 274 282 (Pubitemid 36255590)
3. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., Furukawa Y., Furukawa S., Diabetic neuropathies in brain are induced by deficiency of BDNF Neurotoxicology and Teratology 2002 24 5 695 701 (Pubitemid 35013529)
4. Munshi M., Grande L., Hayes M., Ayres D., Suhl E., Capelson R., Lin S., Milberg W., Katie Weinger E., Cognitive dysfunction is associated with poor diabetes control in older adults Diabetes Care 2006 29 8 1794 1799 (Pubitemid 44156632)
5. Pocai A., Lam T. K. T., Obici S., Gutierrez-Juarez R., Muse E. D., Arduini A., Rossetti L., Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats Journal of Clinical Investigation 2006 116 4 1081 1091
6. Yau J. L. W., McNair K. M., Noble J., Brownstein D., Hibberd C., Morton N., Mullins J. J., Morris R. G. M., Cobb S., Seckl J. R., Enhanced hippocampal long-term potentiation and spatial learning in aged 11 -hydroxysteroid dehydrogenase type 1 knock-out mice Journal of Neuroscience 2007 27 39 10487 10496 (Pubitemid 47502008)
7. Pelletier G., Luu-The V., Li S., Bujold G., Labrie F., Localization and glucocorticoid regulation of 11 -hydroxysteroid dehydrogenase type 1 mRNA in the male mouse forebrain Neuroscience 2007 145 1 110 115 (Pubitemid 46227718)
8. van Bilsen M., van der Vusse G. J., Gilde A. J., Lindhout M., van der Lee K. A. J. M., Peroxisome proliferator-activated receptors: lipid binding proteins controling gene expression Molecular and Cellular Biochemistry 2002 239 1-2 131 138 (Pubitemid 35385804)
9. Vosper H., Khoudoli G. A., Graham T. L., Palmer C. N. A., Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis Pharmacology and Therapeutics 2002 95 1 47 62
10. Gao L., Chiou W. J., Camp H. S., Burns D. J., Cheng X., Quantitative measurements of corticosteroids in ex vivo samples using on-line SPE-LC/MS/MS Journal of Chromatography B 2009 877 3 303 310
11. Du J., Zhang L., Liu S., Zhang C., Huang X., Li J., Zhao N., Wang Z., PPAR transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons Biochemical and Biophysical Research Communications 2009 383 4 485 490
12. Schaaf M. J. M., De Kloet E. R., Vreugdenhil E., Corticosterone effects on BDNF expression in the hippocampus implications for memory formation Stress 2000 3 3 201 208 (Pubitemid 30423178)
13. Yau J. L. W., Noble J., Kenyon C. J., Hibberd C., Kotelevtsev Y., Mullins J. J., Seckl J. R., Lack of tissue glucocorticoid reactivation in 11 -hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4716 4721 (Pubitemid 32295042)
14. Dumas T. C., Gillette T., Ferguson D., Hamilton K., Sapolsky R. M., Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticity Journal of Neuroscience 2010 30 5 1712 1720
15. Holmes M. C., Seckl J. R., The role of 11 -hydroxysteroid dehydrogenases in the brain Molecular and Cellular Endocrinology 2006 248 1-2 9 14
16. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., Greenberg J. H., A peroxisome proliferator-activated receptor- agonist reduces infarct size in transient but not in permanent ischemia Stroke 2005 36 2 353 359 (Pubitemid 40170822)
17. Zhang J., Ge H., Wang C., Guo T. B., He Q., Shao Q., Fan Y., Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells International Journal of Cardiology 2007 117 3 373 380 (Pubitemid 46509807)
18. Berger J., Tanen M., Elbrecht A., Hermanowski-Vosatka A., Moller D. E., Wright S. D., Thieringer R., Peroxisome proliferator-activated receptor- ligands inhibit adipocyte 11 -hydroxysteroid dehydrogenase type 1 expression and activity Journal of Biological Chemistry 2001 276 16 12629 12635
19. Gurnell M., Striking the right balance in targeting PPAR in the metabolic syndrome: novel insights from human genetic studies PPAR Research 2007 2007 14
20. Seckl J. R., 11 -hydroxysteroid dehydrogenases: changing glucocorticoid action Current Opinion in Pharmacology 2004 4 6 597 602 (Pubitemid 40267874)
21. Taylor A., Irwin N., McKillop A. M., Flatt P. R., Gault V. A., Sub-chronic administration of the 11 -HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity Biological Chemistry 2008 389 4 441 445 (Pubitemid 351773918)